Pharmaceutical industry forum to be held in Hamburg
05.04.16
This workshop will cover four distinct themes, including: an overview of the pharmaceutical industry in China and the EU; patient access to innovative drugs in both regions; the Chinese Drug Administration law; the implementation of new EU legislation concerning the identification and authentication of medicines; and, last, but not least, the regulation of clinical trials in the respective geographical areas.
In addition to the presentations that will be made by CPIA and EFPIA members, the European Medicines Agency's Head of Inspections and Human Medicines Pharmacovigilance, Fergus Sweeney, will explore comprehensively the implementation of the EU Clinical Trials Regulation and, representing the European Commission, Patrizia Tosetti will talk extensively regarding the identification and authentication of medicines in Europe, as well as offering insight into the Commission's strategy for pharmaceuticals in the environment.
The end of the workshop will witness a panel discussion between European regulators and representatives from both EFPIA and CPIA covering two highly significant topics: the revision to the Chinese Drug Administration law; and various aspects of implementation in EU legislation.
For more information, contact: Pär Tellner, e-mail: par.tellner@efpia,eu or +32 476 84 08 79.
You can access the agenda here.